Fabrication of Injectable and Expandable PMMA/PAASf Bone Cements

Yufei Tang,Lei Chen,Zixiang Wu,Kang Zhao,Quanchang Tan
DOI: https://doi.org/10.1016/j.compscitech.2017.04.032
IF: 9.1
2017-01-01
Composites Science and Technology
Abstract:The volume of polymethyl methacrylate (PMMA) bone cement shrank by 3.82%-7.08% during solidification. Such volume shrinkage generated a residual stress that induces minor cracking in bone cement interface and affected the long-term stability and mechanical property of vertebral body. In this study, injectable and expandable PMMA/sodium polyacrylate short fiber (PAAS(f)) composite bone cements were fabricated, and water absorption and swelling properties of PAAS(f) were taken into account. Effects of PAAS(f) volume fraction in PMMA/PAAS(f) bone cements on absorption ratios of simulated body fluid (SBF) and volume expansion ratios were investigated. When the volume fraction of PAAS(f) was lower than 30%, PMMA/PAAS(f) bone cements were stable and did not fall apart after expansion in SBF, and the maximum volume expansion ratio was 33.4%. When PAAS(f) content increased from 10 vol% to 30 vol%, solidification time of PMMA/PAAS(f) bone cements increased and their injection and mechanical properties decreased, although the PMMA/PAAS(f) bone cements (9:1) still satisfy the requirements for clinical application. The absorption expansion mechanism of PMMA/PAAS(f) bone cements in SBF in the first stage of expansion (global expansion before solidification) and in the second stage of expansion (local surface expansion after solidification) was analyzed through micro-computed tomography and SEM. Cytotoxicity of PMMA bone cement and PMMA/PAAS(f) bone cements were compared, and results suggested that their cytotoxicity did not significantly vary. These findings indicated that injectable and expandable PMMA/PAAS(f) bone cements can be used in clinical treatments. (C) 2017 Elsevier Ltd. All rights reserved.
What problem does this paper attempt to address?